The Marcus Corporation Reports Fourth Quarter and Full Year Fiscal 2021 Results
The Marcus Corporation (NYSE: MCS) reported notable recovery in the fourth quarter of fiscal 2021, achieving $169 million in revenues, a significant increase from $37 million in Q4 2020. The company marked its second consecutive quarter of profitability, posting a net income of $6.4 million and Adjusted EBITDA of $29.3 million. Full-year 2021 revenues reached $458.2 million, up from $237.7 million in 2020, with a reduced net loss of $43.3 million compared to $124.8 million the previous year. Theatres and hotels both contributed positively to the results, indicating strong market recovery.
- Fourth quarter revenues increased to $169 million from $36.7 million year-over-year.
- Net income for Q4 2021 reached $6.4 million, compared to a net loss of $39 million in Q4 2020.
- Adjusted EBITDA for FY 2021 was $35.1 million, a recovery from a $71.6 million loss in FY 2020.
- Marcus Theatres reported its first profitable quarter since the pandemic onset.
- Full-year operating loss was $41.5 million, although improved from a $178.4 million loss in FY 2020.
The Company reports second consecutive quarter of net earnings and full-year positive Adjusted EBITDA as
“Our recovery continued during the second half of fiscal 2021, with the fourth quarter marking our second consecutive quarter of profitability since the start of the pandemic,” said
Fourth Quarter Fiscal 2021 Highlights
-
Total revenues for the fourth quarter of fiscal 2021 were
, compared to total revenues of$169.0 million for the fourth quarter of fiscal 2020.$36.7 million
-
Operating income was
for the fourth quarter of fiscal 2021, compared to operating loss of$14.0 million for the prior year quarter.$55.2 million
-
Net income attributable to
The Marcus Corporation was for the fourth quarter of fiscal 2021, compared to net loss attributable to$6.4 million The Marcus Corporation of for the same period in fiscal 2020.$39.0 million
-
Net earnings per diluted common share attributable to
The Marcus Corporation was for the fourth quarter of fiscal 2021, compared to net loss per diluted common share attributable to$0.18 The Marcus Corporation of for the fourth quarter of fiscal 2020.$1.29
-
Adjusted EBITDA was
for the fourth quarter of fiscal 2021, compared to a loss of$29.3 million for the prior year quarter.$27.8 million
Adjusted EBITDA reflects adjustments made by the company to eliminate the favorable impact of government grants and federal tax credits received and the impact of nonrecurring impairment charges during the fourth quarter of fiscal 2021 and to eliminate the impact of certain nonrecurring income, expenses and impairment charges during the fourth quarter of fiscal 2020.
Full Year Fiscal 2021 Highlights
-
Total revenues for fiscal 2021 were
, compared to total revenues of$458.2 million for fiscal 2020.$237.7 million
-
Operating loss was
for fiscal 2021, compared to operating loss of$41.5 million for fiscal 2020.$178.4 million
-
Net loss attributable to
The Marcus Corporation was for fiscal 2021, compared to net loss attributable to$43.3 million The Marcus Corporation of for fiscal 2020.$124.8 million
-
Net loss per diluted common share attributable to
The Marcus Corporation was for fiscal 2021, compared to net loss per diluted common share attributable to$1.42 The Marcus Corporation of for fiscal 2020.$4.13
-
Adjusted EBITDA was
for fiscal 2021, compared to a loss of$35.1 million for fiscal 2020.$71.6 million
Adjusted EBITDA reflects adjustments made by the company to eliminate the favorable impact of government grants and federal tax credits received and the impact of impairment charges during fiscal 2021, and to eliminate certain nonrecurring income, expenses and impairment charges during fiscal 2020.
For the first time since the pandemic began,
Comparing admission revenues to pre-pandemic fiscal 2019 results,
“The fourth quarter of fiscal 2021 marked a milestone for
In addition to “Spider Man: No Way Home,” the top five highest-performing films in the fourth quarter of fiscal 2021 were “Venom: Let There Be Carnage,” “Eternals,” “Ghostbusters: Afterlife” and “No Time to Die.” For the full year fiscal 2021, the top five highest-performing films were “Spider Man: No Way Home,” “Black Widow,” “Venom: Let There Be Carnage,” “Shang-Chi and the Legend of the Ten Rings” and “F9: The Fast Saga.”
Looking ahead, the film slate in 2022 is expected to be very strong. Although the number of new films was limited during the first two months of the year, several films contributed to our early first quarter fiscal 2022 results, including the continued performance of “Spider Man: No Way Home,” along with “Sing 2,” “American Underdog,” “Scream,” “Jackass Forever,” “Death on the Nile,” “Uncharted” and “Dog.” “The Batman” opens tonight and studios are currently planning to release a number of additional exciting new films in 2022 including “Morbius,” “Sonic the Hedgehog 2,” “Ambulance,” “Fantastic Beasts: The Secrets of Dumbledore,” “Doctor Strange in the Multiverse of Madness,” “Downton Abbey: A New Era,” “DC Super Pets,” “Top Gun: Maverick,” “Jurassic World: Dominion,” “Lightyear,” “Minions: The Rise of Gru,” “Thor: Love and Thunder,” “Bullet Train,” “Where the Crawdads Sing,” “Black Adam,” “Puss In Boots: The Last Wish,” “Spider-Man: Across the Spider-Verse,” “Halloween Ends,” “The Flash,” “Black Panther: Wakanda Forever,” “Creed III,” “Avatar 2,” “Aquaman 2” and “Mario.”
Comparing RevPAR to pre-pandemic fiscal 2019 results,
“We are encouraged by the pace of our recovery, which accelerated in the second half of 2021,” said
Group booking pace for fiscal 2022, while still behind pre-pandemic pace, has meaningfully improved from the year prior. While the Omicron variant has contributed to delays in the recovery of business travel and shifted some group reservations to later in 2022, booking activity is again improving as Covid-19 case levels decline.
During the fourth quarter of fiscal 2021,
Balance Sheet and Liquidity
The Marcus Corporation’s financial position remains strong with
“Our strong liquidity and capital resources, coupled with our majority-owned real estate position, proved to be considerable assets during one of the most significant global crises of our lifetime,” said
In the fourth quarter of fiscal 2021, the company realized additional proceeds from the sale of non-core real estate assets, ending the fiscal year with over
Diluted weighted average shares outstanding and diluted net earnings per common share include the dilutive effect of conversion of the Company’s convertible notes to the extent conversion is dilutive in each period. During the fourth quarter of fiscal 2021 diluted weighted average shares outstanding includes 9.1 million shares from the dilutive effect of the convertible notes, which were excluded from diluted weighted average shares outstanding in the other periods presented as the convertible notes were antidilutive. Diluted weighted average shares outstanding does not include the benefit from the capped call transactions the Company entered into in connection with the issuance of the convertible notes, which mitigate the dilutive effect of the convertible notes by approximately 3.4 million shares during the fourth quarter of fiscal 2021. Upon conversion, the convertible notes may be settled, at the Company’s election, in cash, shares of common stock or a combination thereof.
Conference Call and Webcast
A telephone replay of the conference call will be available through
Non-GAAP Financial Measure
Adjusted EBITDA has been presented in this press release as a supplemental measure of financial performance that is not required by, or presented in accordance with, GAAP. The company defines Adjusted EBITDA as net earnings (loss) attributable to
Adjusted EBITDA is a key measure used by management and the company’s board of directors to assess the company’s financial performance and enterprise value. The company believes that Adjusted EBITDA is a useful measure, as it eliminates certain expenses and gains that are not indicative of the company’s core operating performance and facilitates a comparison of the company’s core operating performance on a consistent basis from period to period. The company also uses Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of its business strategies, to make budgeting decisions, and to compare its performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.
Adjusted EBITDA is a non-GAAP measure of the company’s financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP and it should not be construed as an inference that the company’s future results will be unaffected by unusual or non-recurring items. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management’s discretionary use. In addition, this non-GAAP measure excludes certain non-recurring and other charges and has its limitations as an analytical tool. You should not consider Adjusted EBITDA in isolation or as a substitute for analysis of the company’s results as reported under GAAP. In evaluating Adjusted EBITDA, you should be aware that in the future the company will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. The company’s presentation of Adjusted EBITDA should not be construed to imply that the company’s future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by the company may not be comparable to the measures disclosed by other companies.
About
Headquartered in
Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects of the COVID-19 pandemic on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the duration of the COVID-19 pandemic and related government restrictions and the level of customer demand following the relaxation of such requirements; (3) the availability, in terms of both quantity and audience appeal, of certain motion pictures for our theatre division (particularly following the COVID-19 pandemic, during which the release dates for motion pictures have been postponed), as well as other industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets, including but not limited to, those caused by the COVID-19 pandemic; (5) the effects of adverse economic conditions, including but not limited to, those caused by the COVID-19 pandemic, on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the COVID-19 pandemic and the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (12) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (13) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in
Consolidated Statements of Earnings (Loss) (Unaudited) (in thousands, except per share data) |
|||||||||||||||
|
13 Weeks
|
|
14 Weeks
|
|
52 Weeks
|
|
53 Weeks
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Revenues: |
|
|
|
|
|
|
|
||||||||
Theatre admissions |
$ |
56,890 |
|
|
$ |
6,158 |
|
|
$ |
130,740 |
|
|
$ |
64,825 |
|
Rooms |
|
20,357 |
|
|
|
7,768 |
|
|
|
77,650 |
|
|
|
35,386 |
|
Theatre concessions |
|
49,734 |
|
|
|
6,434 |
|
|
|
118,666 |
|
|
|
56,711 |
|
Food and beverage |
|
14,852 |
|
|
|
5,202 |
|
|
|
47,086 |
|
|
|
24,822 |
|
Other revenues |
|
20,078 |
|
|
|
7,856 |
|
|
|
65,331 |
|
|
|
38,742 |
|
|
|
161,911 |
|
|
|
33,418 |
|
|
|
439,473 |
|
|
|
220,486 |
|
Cost reimbursements |
|
7,137 |
|
|
|
3,286 |
|
|
|
18,771 |
|
|
|
17,202 |
|
Total revenues |
|
169,048 |
|
|
|
36,704 |
|
|
|
458,244 |
|
|
|
237,688 |
|
|
|
|
|
|
|
|
|
||||||||
Costs and expenses: |
|
|
|
|
|
|
|
||||||||
Theatre operations |
|
53,161 |
|
|
|
15,426 |
|
|
|
140,821 |
|
|
|
92,232 |
|
Rooms |
|
8,375 |
|
|
|
5,111 |
|
|
|
30,394 |
|
|
|
21,243 |
|
Theatre concessions |
|
18,054 |
|
|
|
4,113 |
|
|
|
47,681 |
|
|
|
29,747 |
|
Food and beverage |
|
11,313 |
|
|
|
5,399 |
|
|
|
36,833 |
|
|
|
26,124 |
|
Advertising and marketing |
|
4,874 |
|
|
|
2,628 |
|
|
|
16,069 |
|
|
|
11,074 |
|
Administrative |
|
17,535 |
|
|
|
10,491 |
|
|
|
63,350 |
|
|
|
51,046 |
|
Depreciation and amortization |
|
17,924 |
|
|
|
18,484 |
|
|
|
72,127 |
|
|
|
75,052 |
|
Rent |
|
6,365 |
|
|
|
6,990 |
|
|
|
25,594 |
|
|
|
26,866 |
|
Property taxes |
|
4,331 |
|
|
|
5,556 |
|
|
|
18,473 |
|
|
|
23,560 |
|
Other operating expenses |
|
3,899 |
|
|
|
(806 |
) |
|
|
23,817 |
|
|
|
17,288 |
|
Impairment charges |
|
2,034 |
|
|
|
15,199 |
|
|
|
5,766 |
|
|
|
24,676 |
|
Reimbursed costs |
|
7,137 |
|
|
|
3,286 |
|
|
|
18,771 |
|
|
|
17,202 |
|
Total costs and expenses |
|
155,002 |
|
|
|
91,877 |
|
|
|
499,696 |
|
|
|
416,110 |
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss) |
|
14,046 |
|
|
|
(55,173 |
) |
|
|
(41,452 |
) |
|
|
(178,422 |
) |
|
|
|
|
|
|
|
|
||||||||
Other income (expense): |
|
|
|
|
|
|
|
||||||||
Investment income |
|
446 |
|
|
|
357 |
|
|
|
599 |
|
|
|
564 |
|
Interest expense |
|
(4,352 |
) |
|
|
(6,098 |
) |
|
|
(18,702 |
) |
|
|
(16,275 |
) |
Other income (expense) |
|
(629 |
) |
|
|
785 |
|
|
|
(2,510 |
) |
|
|
(986 |
) |
Gain on disposition of property, equipment and other assets |
|
255 |
|
|
|
1,155 |
|
|
|
3,163 |
|
|
|
856 |
|
Equity losses from unconsolidated joint ventures |
|
(92 |
) |
|
|
— |
|
|
|
(92 |
) |
|
|
(1,539 |
) |
|
|
(4,372 |
) |
|
|
(3,801 |
) |
|
|
(17,542 |
) |
|
|
(17,380 |
) |
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) before income taxes |
|
9,674 |
|
|
|
(58,974 |
) |
|
|
(58,994 |
) |
|
|
(195,802 |
) |
Income tax expense (benefit) |
|
3,230 |
|
|
|
(19,952 |
) |
|
|
(15,701 |
) |
|
|
(70,936 |
) |
Net earnings (loss) attributable to |
|
6,444 |
|
|
|
(39,022 |
) |
|
|
(43,293 |
) |
|
|
(124,866 |
) |
Net loss attributable to noncontrolling interests |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(23 |
) |
Net earnings (loss) attributable to |
$ |
6,444 |
|
|
$ |
(39,022 |
) |
|
$ |
(43,293 |
) |
|
$ |
(124,843 |
) |
|
|
|
|
|
|
|
|
||||||||
Net earnings (loss) per common share attributable to |
|
|
|
|
|
|
|
||||||||
|
$ |
0.18 |
|
|
$ |
(1.29 |
) |
|
$ |
(1.42 |
) |
|
$ |
(4.13 |
) |
|
|
|
|
|
|
|
|
||||||||
Weighted average shares outstanding - diluted |
|
40,607 |
|
|
|
31,064 |
|
|
|
31,360 |
|
|
|
31,042 |
|
Condensed Consolidated Balance Sheets (In thousands) |
|||||
|
(Unaudited) |
|
(Audited) |
||
|
|
|
|
||
|
|
|
|
||
Assets: |
|
|
|
||
|
|
|
|
||
Cash and cash equivalents |
$ |
17,658 |
|
$ |
6,745 |
Restricted cash |
|
6,396 |
|
|
7,343 |
Accounts receivable |
|
28,902 |
|
|
6,359 |
Government grants receivable |
|
4,335 |
|
|
4,913 |
Refundable income taxes |
|
22,435 |
|
|
27,934 |
Assets held for sale |
|
4,856 |
|
|
4,117 |
Other current assets |
|
15,364 |
|
|
10,406 |
Property and equipment, net |
|
771,192 |
|
|
848,328 |
Operating lease right-of-use assets |
|
217,072 |
|
|
229,660 |
Other assets |
|
100,151 |
|
|
108,373 |
|
|
|
|
||
Total Assets |
$ |
1,188,361 |
|
$ |
1,254,178 |
|
|
|
|
||
Liabilities and Shareholders' Equity: |
|
|
|
||
|
|
|
|
||
Accounts payable |
$ |
35,781 |
|
$ |
13,158 |
Taxes other than income taxes |
|
19,566 |
|
|
18,308 |
Other current liabilities |
|
80,152 |
|
|
65,787 |
Short-term borrowings |
|
47,346 |
|
|
87,194 |
Current portion of finance lease obligations |
|
2,561 |
|
|
2,783 |
Current portion of operating lease obligations |
|
16,795 |
|
|
19,614 |
Current maturities of long-term debt |
|
10,967 |
|
|
10,548 |
Finance lease obligations |
|
17,192 |
|
|
19,744 |
Operating lease obligations |
|
216,064 |
|
|
230,550 |
Long-term debt |
|
204,177 |
|
|
193,036 |
Deferred income taxes |
|
26,183 |
|
|
33,429 |
Other long-term obligations |
|
57,963 |
|
|
61,304 |
Equity |
|
453,614 |
|
|
498,723 |
|
|
|
|
||
Total Liabilities and Shareholders' Equity |
$ |
1,188,361 |
|
$ |
1,254,178 |
Business Segment Information (Unaudited) (In thousands) |
|||||||||||||||
|
Theatres |
|
Hotels/
|
|
Corporate
|
|
Total |
||||||||
13 Weeks Ended |
|
|
|
|
|
|
|
||||||||
Revenues |
$ |
116,389 |
|
|
$ |
52,559 |
|
|
$ |
100 |
|
|
$ |
169,048 |
|
Operating income (loss) |
|
18,899 |
|
|
|
354 |
|
|
|
(5,207 |
) |
|
|
14,046 |
|
Depreciation and amortization |
|
12,847 |
|
|
|
5,000 |
|
|
|
77 |
|
|
|
17,924 |
|
Adjusted EBITDA |
|
28,484 |
|
|
|
4,387 |
|
|
|
(3,621 |
) |
|
|
29,250 |
|
|
|
|
|
|
|
|
|
||||||||
14 Weeks Ended |
|
|
|
|
|
|
|
||||||||
Revenues |
$ |
14,210 |
|
|
$ |
22,385 |
|
|
$ |
109 |
|
|
$ |
36,704 |
|
Operating loss |
|
(42,641 |
) |
|
|
(11,426 |
) |
|
|
(1,106 |
) |
|
|
(55,173 |
) |
Depreciation and amortization |
|
13,215 |
|
|
|
5,141 |
|
|
|
128 |
|
|
|
18,484 |
|
Adjusted EBITDA |
|
(18,548 |
) |
|
|
(7,072 |
) |
|
|
(2,150 |
) |
|
|
(27,770 |
) |
|
|
|
|
|
|
|
|
||||||||
52 Weeks Ended |
|
|
|
|
|
|
|
||||||||
Revenues |
$ |
271,248 |
|
|
$ |
186,638 |
|
|
$ |
358 |
|
|
$ |
458,244 |
|
Operating income (loss) |
|
(27,559 |
) |
|
|
5,865 |
|
|
|
(19,758 |
) |
|
|
(41,452 |
) |
Depreciation and amortization |
|
51,654 |
|
|
|
20,192 |
|
|
|
281 |
|
|
|
72,127 |
|
Adjusted EBITDA |
|
24,918 |
|
|
|
24,413 |
|
|
|
(14,251 |
) |
|
|
35,080 |
|
|
|
|
|
|
|
|
|
||||||||
53 Weeks Ended |
|
|
|
|
|
|
|
||||||||
Revenues |
$ |
132,624 |
|
|
$ |
104,638 |
|
|
$ |
426 |
|
|
$ |
237,688 |
|
Operating loss |
|
(121,429 |
) |
|
|
(43,885 |
) |
|
|
(13,108 |
) |
|
|
(178,422 |
) |
Depreciation and amortization |
|
53,460 |
|
|
|
21,096 |
|
|
|
496 |
|
|
|
75,052 |
|
Adjusted EBITDA |
|
(42,176 |
) |
|
|
(17,569 |
) |
|
|
(11,829 |
) |
|
|
(71,574 |
) |
Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information, technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues.
Supplemental Data (Unaudited) (In thousands) |
||||||||||||||||
|
|
13 Weeks
|
|
14 Weeks
|
|
52 Weeks
|
|
53 Weeks
|
||||||||
Consolidated |
|
|
|
|
|
|
|
|
||||||||
Net cash flow provided by (used in) operating activities |
|
$ |
44,194 |
|
|
$ |
12,095 |
|
|
$ |
46,251 |
|
|
$ |
(68,554 |
) |
Net cash flow provided by (used in) investing activities |
|
|
1,635 |
|
|
|
(364 |
) |
|
|
10,883 |
|
|
|
(12,073 |
) |
Net cash flow provided by (used in) financing activities |
|
|
(36,750 |
) |
|
|
(14,396 |
) |
|
|
(47,168 |
) |
|
|
69,097 |
|
Capital expenditures |
|
|
(7,961 |
) |
|
|
(2,676 |
) |
|
|
(17,082 |
) |
|
|
(21,363 |
) |
Reconciliation of Net earnings (loss) to Adjusted EBITDA (Unaudited) (In thousands) |
|||||||||||||||
|
13 Weeks
|
|
14 Weeks
|
|
52 Weeks
|
|
53 Weeks
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Net earnings (loss) attributable to |
$ |
6,444 |
|
|
$ |
(39,022 |
) |
|
$ |
(43,293 |
) |
|
$ |
(124,843 |
) |
Add (deduct): |
|
|
|
|
|
|
|
||||||||
Investment income |
|
(446 |
) |
|
|
(357 |
) |
|
|
(599 |
) |
|
|
(564 |
) |
Interest expense |
|
4,352 |
|
|
|
6,098 |
|
|
|
18,702 |
|
|
|
16,275 |
|
Other expense (income) |
|
629 |
|
|
|
(785 |
) |
|
|
2,510 |
|
|
|
986 |
|
Gain on disposition of property, equipment and other assets |
|
(255 |
) |
|
|
(1,155 |
) |
|
|
(3,163 |
) |
|
|
(856 |
) |
Equity losses from unconsolidated joint ventures |
|
92 |
|
|
|
— |
|
|
|
92 |
|
|
|
1,539 |
|
Net loss attributable to noncontrolling interests |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(23 |
) |
Income tax expense (benefit) |
|
3,230 |
|
|
|
(19,952 |
) |
|
|
(15,701 |
) |
|
|
(70,936 |
) |
Depreciation and amortization |
|
17,924 |
|
|
|
18,484 |
|
|
|
72,127 |
|
|
|
75,052 |
|
Share-based compensation expenses (a) |
|
2,643 |
|
|
|
1,099 |
|
|
|
9,316 |
|
|
|
4,385 |
|
Property closure/reopening expenses - theatres (b) |
|
— |
|
|
|
1,174 |
|
|
|
— |
|
|
|
5,804 |
|
Property closure/reopening expenses - hotels (c) |
|
— |
|
|
|
230 |
|
|
|
— |
|
|
|
5,714 |
|
Impairment charges (d) |
|
2,034 |
|
|
|
15,199 |
|
|
|
5,766 |
|
|
|
24,676 |
|
Government grants and federal tax credits (e) |
|
(7,397 |
) |
|
|
(6,955 |
) |
|
|
(10,677 |
) |
|
|
(6,955 |
) |
Insurance proceeds (f) |
|
— |
|
|
|
(1,828 |
) |
|
|
— |
|
|
|
(1,828 |
) |
Adjusted EBITDA |
$ |
29,250 |
|
|
$ |
(27,770 |
) |
|
$ |
35,080 |
|
|
$ |
(71,574 |
) |
(a) |
Non-cash charges related to share-based compensation programs. |
|
(b) |
Reflects nonrecurring costs (primarily payroll) related to the required closure of all of the company's movie theatres due to the COVID-19 pandemic, plus subsequent nonrecurring costs related to reopening theatres. |
|
(c) |
Reflects nonrecurring costs related to the closure of the company's hotels and resorts due to reduced occupancy as a result of the COVID-19 pandemic, plus subsequent nonrecurring costs related to reopening hotels. |
|
(d) |
Non-cash impairment charges related to two operating theatres, three permanently closed theatres and surplus theatre real estate for the fiscal 2021 periods and intangible assets (trade name) and several theatre locations for the fiscal 2020 and fiscal 2019 periods. |
|
(e) |
Reflects nonrecurring state government grants and federal tax credits awarded to our theatres and hotels for COVID-19 relief. |
|
(f) |
Reflects nonrecurring net insurance proceeds received for COVID-19 related insurance claims. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220302006092/en/
(414) 905-1100
investors@marcuscorp.com
Source:
FAQ
What were the Q4 2021 earnings results for Marcus Corporation (MCS)?
How did Marcus Corporation's Adjusted EBITDA perform in FY 2021?